{
  "pmcid": "4912949",
  "sha256": "10805ee6094f45e29aa1e303713f1b08a2f4f17b53698c8cf4dd3a4b3439ac0e",
  "timestamp_utc": "2025-11-09T22:44:26.275715+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.958561250287293,
    "reading_ease": 37.962277637324775,
    "word_count": 229
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial of Bilateral Deep Brain Stimulation of the Fornix in Mild, Probable Alzheimer’s Disease"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Randomisation was conducted at the patient level"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were patients with mild, probable AD, recruited between June 6, 2012, and April 28, 2014."
      },
      "Intervention": {
        "score": 2,
        "evidence": "A total of 42 patients were randomised to receive bilateral fornix DBS."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the safety, efficacy, and tolerability of bilateral deep brain stimulation (DBS) of the fornix in patients with mild, probable Alzheimer’s disease (AD)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the 90-day perioperative safety of the procedure."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was conducted at the patient level, with allocation concealment ensured."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding was maintained for outcome assessors, patients, and clinicians."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 42 patients were randomised to receive bilateral fornix DBS."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "A total of 42 patients were randomised to receive bilateral fornix DBS."
      },
      "Harms": {
        "score": 1,
        "evidence": "Twenty-six patients (61.9%) experienced 64 adverse events (AEs) related to the study procedure, with 7 serious AEs in 5 patients (11.9%)."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]."
      }
    },
    "total_score": 18,
    "max_score": 25
  }
}